Multiinstuituional prospective study for evaluating the efficacy of oral nutritional supplements to the gastric cancer patients after gastrectomy

Multiinstuituional prospective study for evaluating the efficacy of oral nutritional supplements to the gastric cancer patients after gastrectomy - CCOG1301

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011410

Enrollment

100

Registered

2013-09-01

Start date

2013-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Oral nutritional supplements

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Gastric cancer patients who are diagnosed to be Stage 1,2 and 3 according to the Japanease classification for gastric cancer 2. Patients who are going to undergo distal gastrectomy or total gastrectomy

Exclusion criteria

Exclusion criteria: 1. Patients who need to restrict food or water intake 2. Patients who have comlicating diseases that cause body weight loss 3. Patients with contraindication for taking Racol

Design outcomes

Primary

Measure	Time frame
Variation of body composition 3 months after gastrectomy	—

Countries

Japan

Contacts

Public ContactDaisuke Kobayashi

Nagoya University, Graduate School of Medicine Gastroenterorogical Surgery

kobadai@med.nagoya-u.ac.jp052-744-2253

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026